Infection Prevention and Control Strategies According to the Type of Multidrug-Resistant Bacteria and in Intensive Care Units: A Pragmatic Resume including Pathogens R and a Cost-Effectiveness Analysis.

Chiara Fanelli, Laura Pistidda, Pierpaolo Terragni, Daniela Pasero
Author Information
  1. Chiara Fanelli: Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy. ORCID
  2. Laura Pistidda: Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy. ORCID
  3. Pierpaolo Terragni: Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.
  4. Daniela Pasero: Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.

Abstract

Multidrug-resistant organism (MDRO) outbreaks have been steadily increasing in intensive care units (ICUs). Still, healthcare institutions and workers (HCWs) have not reached unanimity on how and when to implement infection prevention and control (IPC) strategies. We aimed to provide a pragmatic physician practice-oriented resume of strategies towards different MDRO outbreaks in ICUs. We performed a narrative review on IPC in ICUs, investigating patient-to-staff ratios; education, isolation, decolonization, screening, and hygiene practices; outbreak reporting; cost-effectiveness; reproduction numbers (R); and future perspectives. The most effective IPC strategy remains unknown. Most studies focus on a specific pathogen or disease, making the clinician lose sight of the big picture. IPC strategies have proven their cost-effectiveness regardless of typology, country, and pathogen. A standardized, universal, pragmatic protocol for HCW education should be elaborated. Likewise, the elaboration of a rapid outbreak recognition tool (i.e., an easy-to-use mathematical model) would improve early diagnosis and prevent spreading. Further studies are needed to express views in favor or against MDRO decolonization. New promising strategies are emerging and need to be tested in the field. The lack of IPC strategy application has made and still makes ICUs major MDRO reservoirs in the community. In a not-too-distant future, genetic engineering and phage therapies could represent a plot twist in MDRO IPC strategies.

Keywords

References

  1. Antimicrob Agents Chemother. 2017 Aug 24;61(9): [PMID: 28717037]
  2. J Hosp Infect. 2016 May;93(1):29-34 [PMID: 26876749]
  3. Proc Natl Acad Sci U S A. 2022 Nov 08;119(45):e2204993119 [PMID: 36322765]
  4. Lancet Infect Dis. 2021 Aug;21(8):e246-e257 [PMID: 33606997]
  5. Am J Infect Control. 2013 Dec;41(12):1167-72 [PMID: 24274912]
  6. Infect Control Hosp Epidemiol. 2010 Aug;31(8):850-3 [PMID: 20569115]
  7. Infect Control Hosp Epidemiol. 2008 Nov;29(11):1035-41 [PMID: 18851687]
  8. Antimicrob Agents Chemother. 2011 Jul;55(7):3485-90 [PMID: 21537020]
  9. Scand J Infect Dis. 2011 Jul;43(6-7):456-62 [PMID: 21366406]
  10. Cells. 2020 Nov 02;9(11): [PMID: 33147722]
  11. Int J Antimicrob Agents. 2019 Oct;54(4):527-529 [PMID: 31279151]
  12. Intensive Crit Care Nurs. 2018 Jun;46:1-3 [PMID: 29395569]
  13. HERD. 2021 Oct;14(4):368-415 [PMID: 34000842]
  14. Nurs Crit Care. 2010 May-Jun;15(3):109-11 [PMID: 20500648]
  15. Crit Care Med. 2015 Aug;43(8):1587-94 [PMID: 25867907]
  16. FEMS Microbiol Rev. 2020 Jan 1;44(1):123-153 [PMID: 31841134]
  17. JAC Antimicrob Resist. 2022 Sep 30;4(5):dlac094 [PMID: 36196443]
  18. Crit Care Explor. 2022 Oct 13;4(10):e0774 [PMID: 36259061]
  19. Curr Opin Infect Dis. 2017 Aug;30(4):432-439 [PMID: 28520621]
  20. Elife. 2022 Jun 28;11: [PMID: 35762734]
  21. J Hosp Infect. 2018 Feb;98(2):202-211 [PMID: 28807836]
  22. Crit Care Explor. 2020 Dec 16;2(12):e0301 [PMID: 33354675]
  23. Clin Infect Dis. 1994 Dec;19(6):1123-8 [PMID: 7888543]
  24. Lancet Infect Dis. 2017 May;17(5):476 [PMID: 28447947]
  25. Am J Infect Control. 2018 Jun;46(6):643-648 [PMID: 29398072]
  26. Trop Med Infect Dis. 2022 Nov 09;7(11): [PMID: 36355907]
  27. Crit Care Nurs Q. 2011 Jan-Mar;34(1):46-51 [PMID: 21160300]
  28. J Appl Microbiol. 2016 Nov;121(5):1223-1231 [PMID: 27495010]
  29. Intensive Crit Care Nurs. 2023 Apr;75:103342 [PMID: 36464606]
  30. Comput Math Methods Med. 2015;2015:207105 [PMID: 26451161]
  31. Travel Med Infect Dis. 2024 Jan-Feb;57:102685 [PMID: 38181864]
  32. Am J Med. 2008 Apr;121(4):310-5 [PMID: 18374690]
  33. Front Cell Infect Microbiol. 2024 Mar 20;14:1361045 [PMID: 38572320]
  34. J Hosp Infect. 2022 Feb;120:14-22 [PMID: 34688796]
  35. Clin Microbiol Infect. 2017 Mar;23(3):188-196 [PMID: 27746394]
  36. Clin Infect Dis. 2022 Oct 12;75(8):1433-1441 [PMID: 35143641]
  37. J Family Med Prim Care. 2020 Jun 30;9(6):2631-2637 [PMID: 32984099]
  38. Ann Am Thorac Soc. 2013 Jun;10(3):220-7 [PMID: 23802818]
  39. Infect Dis Ther. 2022 Feb;11(1):617-628 [PMID: 34751941]
  40. Clin Microbiol Infect. 2021 Oct;27(10):1448-1454 [PMID: 33878506]
  41. JAMA. 1999 Nov 10;282(18):1745-51 [PMID: 10568647]
  42. Hum Vaccin Immunother. 2021 Nov 2;17(11):3850-3854 [PMID: 34612165]
  43. Chest. 2005 Aug;128(2):567-72 [PMID: 16100139]
  44. Clin Infect Dis. 2001 May 15;32(10):1393-8 [PMID: 11317238]
  45. Clin Microbiol Infect. 2014 Jan;20 Suppl 1:1-55 [PMID: 24329732]
  46. Am J Infect Control. 2023 Jul;51(7):807-811 [PMID: 36306861]
  47. Clin Infect Dis. 2019 Aug 16;69(5):769-776 [PMID: 30462182]
  48. Med Princ Pract. 2021;30(6):535-541 [PMID: 34818250]
  49. PLoS One. 2014 Jan 03;9(1):e83778 [PMID: 24404138]
  50. Heliyon. 2023 Apr 13;9(4):e15424 [PMID: 37128312]
  51. Cureus. 2023 Oct 16;15(10):e47139 [PMID: 38021721]
  52. Saudi J Kidney Dis Transpl. 2019 Nov-Dec;30(6):1351-1363 [PMID: 31929282]
  53. Am J Infect Control. 2008 May;36(4):283-90 [PMID: 18455049]
  54. Nurs Clin North Am. 2019 Jun;54(2):169-180 [PMID: 31027659]
  55. Sci Rep. 2024 Jan 28;14(1):2317 [PMID: 38282072]
  56. Intensive Care Med. 2015 Dec;41(12):2057-75 [PMID: 26438224]
  57. Surg Infect (Larchmt). 2009 Apr;10(2):137-42 [PMID: 19388836]
  58. Infect Control Hosp Epidemiol. 2016 Nov;37(11):1315-1322 [PMID: 27609341]
  59. J Hosp Infect. 2018 Sep;100(1):83-91 [PMID: 29530743]
  60. J Infect. 2019 Dec;79(6):601-611 [PMID: 31557493]
  61. Emerg Infect Dis. 2020 Sep;26(9):2182-2185 [PMID: 32818397]
  62. Am J Infect Control. 2014 Mar;42(3):283-7 [PMID: 24581017]
  63. Clin Microbiol Infect. 2023 Apr;29(4):463-479 [PMID: 36566836]
  64. Clin Microbiol Infect. 2024 Mar;30(3):336-352 [PMID: 38101471]
  65. Infect Control Hosp Epidemiol. 2007 Jun;28(6):743-4 [PMID: 17520554]
  66. Intensive Care Med. 2020 Nov;46(11):2001-2014 [PMID: 32990778]
  67. Int Microbiol. 2017 Dec;20(4):165-169 [PMID: 29529327]
  68. BMC Infect Dis. 2014 Sep 23;14:514 [PMID: 25248287]
  69. Infect Control Hosp Epidemiol. 2022 Oct;43(10):1368-1374 [PMID: 35959529]
  70. Lancet Infect Dis. 2007 Apr;7(4):282-8 [PMID: 17376385]
  71. Intensive Care Med. 2007 May;33(5):836-840 [PMID: 17347828]
  72. J Antimicrob Chemother. 2010 Jan;65(1):156-62 [PMID: 19910328]
  73. Arch Intern Med. 2009 Jul 27;169(14):1290-8 [PMID: 19636030]
  74. Crit Care Med. 2017 Aug;45(8):1325-1336 [PMID: 28437376]
  75. Antimicrob Resist Infect Control. 2019 Dec 4;8:199 [PMID: 31827780]
  76. Math Biosci Eng. 2013 Oct-Dec;10(5-6):1455-74 [PMID: 24245625]
  77. Antimicrob Steward Healthc Epidemiol. 2021 Dec 13;1(1):e62 [PMID: 36168472]
  78. Clin Microbiol Infect. 2016 Nov;22(11):949.e5-949.e7 [PMID: 27596532]
  79. JAC Antimicrob Resist. 2023 Aug 10;5(4):dlad096 [PMID: 37577156]
  80. Can J Infect Dis Med Microbiol. 2023 Dec 21;2023:8265683 [PMID: 38156310]
  81. Epidemiol Infect. 2017 Jun;145(8):1649-1657 [PMID: 28240195]
  82. Antimicrob Resist Infect Control. 2017 Nov 15;6:113 [PMID: 29163939]
  83. J Infect Public Health. 2019 Nov - Dec;12(6):904-906 [PMID: 31078493]
  84. N Engl J Med. 2013 Jun 13;368(24):2255-65 [PMID: 23718152]
  85. Clinics (Sao Paulo). 2013;68(8):1128-33 [PMID: 24037009]
  86. Infect Control Hosp Epidemiol. 2014 Apr;35(4):434-6 [PMID: 24602952]
  87. Antimicrob Resist Infect Control. 2021 Apr 8;10(1):69 [PMID: 33832538]
  88. Eur J Clin Microbiol Infect Dis. 2011 Dec;30(12):1473-81 [PMID: 21499954]
  89. BMC Infect Dis. 2014 Mar 31;14:177 [PMID: 24678646]
  90. Crit Care Med. 2019 Sep;47(9):1251-1257 [PMID: 31219838]
  91. Science. 2023 Jul 14;381(6654):164-170 [PMID: 37440620]
  92. Intensive Care Med. 2022 Feb;48(2):225-226 [PMID: 35024883]
  93. Virulence. 2013 Feb 15;4(2):163-71 [PMID: 23302791]
  94. Infect Control Hosp Epidemiol. 2016 Mar;37(3):289-94 [PMID: 26669221]
  95. Microbiol Spectr. 2021 Oct 31;9(2):e0035621 [PMID: 34523992]
  96. Ann Surg. 1994 Dec;220(6):751-8 [PMID: 7986142]
  97. Infect Control Hosp Epidemiol. 2014 Jul;35(7):810-7 [PMID: 24915208]
  98. Front Med (Lausanne). 2021 Feb 23;8:575580 [PMID: 33708775]
  99. Infection. 2013 Feb;41(1):33-40 [PMID: 22782694]
  100. Diagn Microbiol Infect Dis. 2013 Oct;77(2):169-73 [PMID: 23886789]
  101. Clin Microbiol Infect. 2019 Jul;25(7):807-817 [PMID: 30708122]
  102. Crit Care Med. 2006 Mar;34(3):730-7 [PMID: 16505659]
  103. Am J Infect Control. 2013 Nov;41(11):1043-7 [PMID: 23706830]
  104. Antimicrob Resist Infect Control. 2019 Oct 29;8:168 [PMID: 31687132]
  105. Can J Vet Res. 2004 Jan;68(1):19-26 [PMID: 14979431]
  106. Open Forum Infect Dis. 2023 Nov 10;10(11):ofad567 [PMID: 38023537]
  107. Postgrad Med J. 2002 Jul;78(921):385-92 [PMID: 12151652]
  108. Crit Care. 2018 Nov 21;22(1):319 [PMID: 30463589]
  109. Nurs Crit Care. 2023 Mar;28(2):281-287 [PMID: 35896444]
  110. Intensive Crit Care Nurs. 2022 Jun;70:103227 [PMID: 35249794]
  111. Infect Control Hosp Epidemiol. 1999 Jul;20(7):458-60 [PMID: 10432154]
  112. Clin Infect Dis. 2022 Aug 31;75(3):416-424 [PMID: 34849648]
  113. PLoS Curr. 2014 Dec 18;6: [PMID: 25685622]
  114. J Infect Dis. 2006 May 15;193(10):1408-18 [PMID: 16619189]
  115. Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1811-7 [PMID: 22246509]
  116. Intensive Care Med. 2020 Aug;46(8):1536-1551 [PMID: 32591853]
  117. PLoS One. 2013 Dec 20;8(12):e84224 [PMID: 24376797]
  118. J Antimicrob Chemother. 2016 Apr;71(4):927-35 [PMID: 26747103]
  119. J Antimicrob Chemother. 2008 Nov;62(5):1130-7 [PMID: 18635519]
  120. BMC Infect Dis. 2006 Aug 16;6:130 [PMID: 16914034]
  121. J Hosp Infect. 2020 Nov;106(3):447-453 [PMID: 32927013]
  122. Infect Control Hosp Epidemiol. 2023 Jul;44(7):1039-1067 [PMID: 37381690]
  123. Pathogens. 2023 Dec 13;12(12): [PMID: 38133327]
  124. BMC Infect Dis. 2018 Mar 7;18(1):116 [PMID: 29514595]
  125. Am J Respir Crit Care Med. 2017 Jul 1;196(1):56-63 [PMID: 27936874]
  126. Infect Control Hosp Epidemiol. 2017 Oct;38(10):1240-1243 [PMID: 28793937]
  127. Infect Control Hosp Epidemiol. 2000 Feb;21(2):80-5 [PMID: 10697282]
  128. Int J Nurs Stud. 2014 May;51(5):781-94 [PMID: 24636667]
  129. J Hosp Infect. 2016 Jan;92(1):47-53 [PMID: 26616413]
  130. JAMA Intern Med. 2017 Mar 1;177(3):388-396 [PMID: 28118657]
  131. Curr Treat Options Infect Dis. 2020;12(2):135-144 [PMID: 32218708]
  132. J Infect Dev Ctries. 2018 Jul 31;12(7):581-586 [PMID: 31954008]
  133. J Antimicrob Chemother. 2022 Nov 28;77(12):3331-3339 [PMID: 36203392]
  134. Cochrane Database Syst Rev. 2016 Aug 22;(8):CD010669 [PMID: 27546228]
  135. Ann Clin Microbiol Antimicrob. 2023 Jan 10;22(1):3 [PMID: 36627626]
  136. J Hosp Infect. 2012 Feb;80(2):133-9 [PMID: 22188631]
  137. Sci Rep. 2023 Sep 15;13(1):15282 [PMID: 37714922]
  138. Proc Biol Sci. 2014 Jan 08;281(1777):20132676 [PMID: 24403333]
  139. J Clin Microbiol. 2019 Aug 26;57(9): [PMID: 31315959]
  140. Am J Infect Control. 2023 Nov;51(11S):A64-A71 [PMID: 37890955]
  141. Intensive Care Med. 2023 May;49(5):545-553 [PMID: 37133740]
  142. Infect Control Hosp Epidemiol. 2007 Oct;28(10):1155-61 [PMID: 17828692]
  143. Heliyon. 2021 Jan 21;7(1):e06023 [PMID: 33532645]
  144. Lancet Infect Dis. 2017 Dec;17(12):e420-e428 [PMID: 28757186]
  145. J Hosp Infect. 2016 Sep;94(1):54-9 [PMID: 27392978]
  146. Rev Esc Enferm USP. 2016 Jul-Aug;50(4):683-694 [PMID: 27680056]
  147. Am J Infect Control. 2023 Oct;51(10):1175-1181 [PMID: 36924997]
  148. Infect Control Hosp Epidemiol. 2020 Feb;41(2):166-171 [PMID: 31722777]
  149. Medicine (Baltimore). 2019 Feb;98(8):e14417 [PMID: 30813142]
  150. Infect Control Hosp Epidemiol. 2012 Jan;33(1):14-9 [PMID: 22173517]
  151. Infect Control Hosp Epidemiol. 2022 Sep;43(9):1162-1170 [PMID: 34674791]
  152. Intensive Care Med. 2022 Feb;48(2):179-189 [PMID: 34854939]
  153. Annu Rev Med. 2022 Jan 27;73:197-211 [PMID: 34428079]
  154. J Hosp Infect. 2013 Sep;85(1):54-9 [PMID: 23920443]
  155. Antimicrob Resist Infect Control. 2022 Nov 22;11(1):143 [PMID: 36414999]
  156. Medicine (Baltimore). 2021 Jan 22;100(3):e23686 [PMID: 33545935]
  157. Int J Environ Res Public Health. 2020 Mar 22;17(6): [PMID: 32235764]
  158. J Hosp Infect. 2017 Apr;95(4):421-425 [PMID: 28169013]
  159. Mycoses. 2011 Jan;54(1):46-51 [PMID: 19627509]
  160. BMC Infect Dis. 2016 Aug 25;16(1):447 [PMID: 27562241]
  161. J Antimicrob Chemother. 2023 Oct 3;78(10):2505-2514 [PMID: 37606528]
  162. Infect Control Hosp Epidemiol. 2017 Mar;38(3):266-272 [PMID: 27989244]
  163. Am J Infect Control. 2017 Dec 1;45(12):1372-1377 [PMID: 28844384]
  164. PLoS One. 2013 May 07;8(5):e63716 [PMID: 23667661]
  165. Antimicrob Resist Infect Control. 2021 Aug 19;10(1):123 [PMID: 34412693]
  166. New Microbiol. 2024 Jan;46(4):395-399 [PMID: 38252051]
  167. Microbiol Spectr. 2023 Mar 28;:e0020923 [PMID: 36976013]
  168. Clin Infect Dis. 2015 Jul 15;61(2):145-54 [PMID: 25824815]
  169. Antimicrob Steward Healthc Epidemiol. 2023 Sep 26;3(1):e162 [PMID: 37771737]
  170. J Mycol Med. 2018 Jun;28(2):249-256 [PMID: 29567285]
  171. Clin Infect Dis. 2016 Jun 1;62(11):1423-35 [PMID: 26936670]
  172. Infect Control Hosp Epidemiol. 2007 Nov;28(11):1247-54 [PMID: 17926275]
  173. J Hosp Infect. 2016 Feb;92(2):194-8 [PMID: 26778130]
  174. Antimicrob Resist Infect Control. 2018 Nov 21;7:140 [PMID: 30479753]
  175. Antimicrob Resist Infect Control. 2023 Sep 4;12(1):90 [PMID: 37667340]
  176. J Infect. 2018 Oct;77(4):349-356 [PMID: 30067944]
  177. PLoS One. 2022 Feb 3;17(2):e0260580 [PMID: 35113884]
  178. Clin Infect Dis. 2013 Feb;56(4):527-35 [PMID: 23087397]

Word Cloud

Created with Highcharts 10.0.0IPCMDROstrategiesICUsdecolonizationoutbreakoutbreaksinfectionpreventioncontrolpragmaticeducationcost-effectivenessreproductionRfuturestrategystudiespathogenMultidrug-resistantorganismsteadilyincreasingintensivecareunitsStillhealthcareinstitutionsworkersHCWsreachedunanimityimplementaimedprovidephysicianpractice-orientedresumetowardsdifferentperformednarrativereviewinvestigatingpatient-to-staffratiosisolationscreeninghygienepracticesreportingnumbersperspectiveseffectiveremainsunknownfocusspecificdiseasemakingclinicianlosesightbigpictureprovenregardlesstypologycountrystandardizeduniversalprotocolHCWelaboratedLikewiseelaborationrapidrecognitiontoolieeasy-to-usemathematicalmodelimproveearlydiagnosispreventspreadingneededexpressviewsfavorNewpromisingemergingneedtestedfieldlackapplicationmadestillmakesmajorreservoirscommunitynot-too-distantgeneticengineeringphagetherapiesrepresentplottwistInfectionPreventionControlStrategiesAccordingTypeMultidrug-ResistantBacteriaIntensiveCareUnits:PragmaticResumeincludingPathogensCost-EffectivenessAnalysisAcinetobacterbaumaniiCandidaaurisKPCVREbasicnumberhospital-acquiredinfectionsmultidrug-resistantbacteria

Similar Articles

Cited By